1. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling
   Shuai Huang et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
2. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma
   Wanli Yu et al, 2018, NeuroMolecular Medicine CrossRef
3. Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancer
   Yujie Zhong et al, 2021, Molecular Oncology CrossRef
4. miR‑128‑3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS‑1/PI3K/AKT signaling pathway
   Leiming Huo et al, 2019, Experimental and Therapeutic Medicine CrossRef
5. LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis
   Hongchao Xu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
6. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells
   Mohamed A. Ragheb et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
7. The flavonoid rutin and its aglycone quercetin modulate the microglia inflammatory profile improving antiglioma activity
   Alessandra Bispo da Silva et al, 2020, Brain, Behavior, and Immunity CrossRef
8. MicroRNA‐520c‐3p functions as a novel tumor suppressor in lung adenocarcinoma
   Xiaofeng Li et al, 2019, The FEBS Journal CrossRef
9. The Role of microRNAs in Multidrug Resistance of Glioblastoma
   Parvaneh Mahinfar et al, 2022, Cancers CrossRef
10. RETRACTED: The Potential Therapeutic Role of Exosomal MicroRNA-520b Derived from Normal Fibroblasts in Pancreatic Cancer
    Huijuan Shi et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
11. Therapeutic Implications of TGFβ in Cancer Treatment: A Systematic Review
    Verónica Gómez-Gil, 2021, Cancers CrossRef
12. miR‑7‑5p inhibits cell migration and invasion in glioblastoma through targeting SATB1
    Chang‑You Yin et al, 2018, Oncology Letters CrossRef
13. Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
    Johannes Fänder et al, 2019, Oncotarget CrossRef